Stocks and Investing
Stocks and Investing
Mon, December 19, 2016
[ 12:00 AM ] - United States, WOPRAI
Fri, December 16, 2016
[ 06:46 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Alethia Young Initiated (BIIB) at Hold and Held Target at $293 on, Dec 16th, 2016
Alethia Young of Cantor Fitzgerald, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $293 on, Dec 16th, 2016.
Alethia has made no other calls on BIIB in the last 4 months.
There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Salim Syed of "Mizuho" Initiated at Hold and Held Target at $290 on, Tuesday, November 8th, 2016
- Eun Yang of "Jefferies" Maintained at Hold with Decreased Target to $316 on, Wednesday, October 5th, 2016
These are the ratings of the 3 analyists that currently disagree with Alethia
- Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy on, Monday, November 7th, 2016
- Geoffrey Porges of "Leerink Swann" Upgraded from Hold to Buy on, Monday, November 7th, 2016
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $368 on, Wednesday, August 17th, 2016
Contributing Sources